探索皮肤癌中的m6A甲基化:洞察分子机制和治疗方法
Mingjun Cai1, Xueqing Li1, Xueyu Luan1
1Department of Dermatology, Qilu Hospital, Shandong University, Jinan 250012, Shandong, China.
Cellular signalling
|September 20, 2024
概括
N6-甲基氨酸 (m6A) 是一种影响皮肤癌的关键RNA修饰. 这篇评论详细介绍了m6AA的细节.
科学领域:
- 表观遗传学和分子生物学
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- N6-甲基氨酸 (m6A) 是真核生物中最常见的内部mRNA修饰.
- m6A调节关键的RNA过程,包括拼接,翻译和降解.
- 皮肤癌,如黑色素瘤和非黑色素瘤皮肤癌 (NMSCs),是全球普遍存在的恶性瘤.
研究的目的:
- 综合审查m6A.的生物功能.
- 总结目前关于皮肤癌中m6ARNA修饰的证据.
- 突出m6A在皮肤癌诊断和治疗中的潜在临床应用.
主要方法:
- 关于m6ARNA修饰的文献综述.
- 分析m6A在皮肤癌病理生理学中的作用.
- 检查m6A在皮肤癌中的临床相关性.
主要成果:
- 异常的m6A修饰与皮肤癌的进展有关.
- m6A影响瘤细胞的增殖,入侵,迁移和转移.
- m6A失调与皮肤癌的发展和进展有关.
结论:
- m6A在皮肤癌的分子机制中发挥着重要作用.
- 针对m6A途径提供了新的诊断和治疗策略的潜力.
- 对m6A修饰的进一步研究可能会彻底改变皮肤癌管理.
相关概念视频
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Phase II Reactions: Methylation Reactions
156
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
156
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


